Valuation (5%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -40.97 | -15.27 |
| PEG Ratio (TTM) | -7.62 | -4.35 |
| P/S Ratio (TTM) | N/A | 45.97 |
| P/B Ratio (TTM) | 19.87 | 28.96 |
| P/FCF Ratio (TTM) | -2.71 | -2.59 |
| Price to 5YR AVG Earnings Ratio | -4.50 | -5.56 |
| Price to 5YR AVG FCF Ratio | -6.15 | -12.33 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -47.14% | -19.06% |
| ROE (TTM) | -52.19% | 15.70% |
| Net Profit Margin (TTM) | N/A | -813.88% |
| ROIC 5YR AVG | -180.04% | 3.12% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -678.71% | -389.24% | -1,067.41% |
| Revenue | N/A | -33.33% | -20.00% |
| Net Income | -95.18% | -1,170.98% | -712.81% |
| Cash Flow | -33.28% | -457,930.23% | -274,796.14% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 24.24 | 5.56 |
| Quick Ratio (TTM) | 24.24 | 5.34 |
| D/E Ratio (TTM) | N/A | 0.95 |
| Interest Coverage (TTM) | N/A | -6.44 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 12.98 | 12.45 |
| LTL to 5YR AVG FCF | N/A | 0.11 |
| Shares Outstanding Growth 5YR AVG | 64.23% | 37.46% |